Boston Scientific (BSX) gains after topping Q1 estimates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- Funds sell $44bn in semiconductors on AI concerns
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
Boston Scientific (BSX) Tops Q1 EPS by 4c; offers guidance
April 26, 2023 6:32 AM EDTBoston Scientific (NYSE: BSX) reported Q1 EPS of $0.47, $0.04 better than the analyst estimate of $0.43. Revenue for the quarter came in at $3.39 billion versus the consensus estimate of $3.16 billion.
GUIDANCE:
Boston Scientific sees Q2 2023 EPS of $0.48-$0.50, versus the consensus of... More
